@article{0d19562d09d34d45b71dde26eafdee2d,
title = "がん疼痛患者におけるオピオイド誘発性便秘症",
keywords = "下痢(化学的誘発), *オピオイド系鎮痛剤(毒性・副作用,治療的利用), 投薬計画, 離脱症候群, 有病率, Mu Opioid Receptors(拮抗物質・阻害物質), 診療ガイドライン, *癌性疼痛(薬物療法), Lubiprostone(治療的利用), 疼痛管理, Naldemedine(毒性・副作用,治療的利用), *オピオイド誘発性便秘(診断,薬物療法), 病態生理, ヒト",
author = "有賀 悦子",
year = "2021",
month = nov,
language = "Japanese",
volume = "48",
pages = "1311--1315",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "11",
}